Predicting potential adverse events using safety data from marketed drugs

被引：0
|
作者：
Chathuri Daluwatte
Peter Schotland
David G. Strauss
Keith K. Burkhart
Rebecca Racz
机构：
[1] Food and Drug Administration,Division of Applied Regulatory Science
[2] Food and Drug Administration,Office of New Drugs
来源：
BMC Bioinformatics | / 21卷
关键词：
Adverse reaction; Pharmacovigilance; Classifier; Computational biology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Regrouping of adverse events to better present safety data in statistical report
    Poncet, C.
    El Hachemi, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 55 - 55
  • [32] POTENTIAL PREVENTABILITY OF ADVERSE DRUG EVENTS INVOLVING MULTIPLE DRUGS USING PUBLIC CLINICAL DECISION SUPPORT RULES
    Feblowitz, Joshua Colin
    Wright, Adam
    Phansalkar, Shobha
    Bates, David W.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S59 - S59
  • [33] Predicting serious adverse events or a safety net - Rethinking the role of early warning scores
    Haegdorens, Filip
    RESUSCITATION PLUS, 2024, 17
  • [34] Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example
    Xiong, Rui
    Lei, Jing
    Wang, Lu
    Zhang, Shipeng
    Liu, Hengxu
    Wang, Hongping
    Liu, Tao
    Lai, Xiaodan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Predicting potential distributions of geographic events using one-class data: concepts and methods
    Guo, Q.
    Li, W.
    Liu, Y.
    Tong, D.
    INTERNATIONAL JOURNAL OF GEOGRAPHICAL INFORMATION SCIENCE, 2011, 25 (10) : 1697 - 1715
  • [36] Root Cause Analysis: Learning from Adverse Safety Events
    Brook, Olga R.
    Kruskal, Jonathan B.
    Eisenberg, Ronald L.
    Larson, David B.
    RADIOGRAPHICS, 2015, 35 (06) : 1655 - 1667
  • [37] SAFETY OF BIOSIMILAR ETANERCEPT IN THE TREATMENT OF RHEUMATIC DISEASES: DATA FROM THE MEXICAN ADVERSE EVENTS REGISTRY (BIOBADAMEX)
    Rivera Teran, V.
    Perez Rodriguez, M.
    Alpizar-Rodriguez, D.
    Irazoque-Palazuelos, F.
    Carrilo, S.
    Sicsik, S.
    Vega-Morales, D.
    Miranda, D.
    Castillo, A.
    Casasola, J. C.
    Pacheco Tena, C. F.
    Moctezuma, J. F.
    Aceves, F.
    Paz, A.
    Duran Barragan, S.
    Barile, L.
    Santana, N.
    Xibille Friedmann, D. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1901 - 1902
  • [38] Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry
    Vyzhga, Yulia
    Frenkel, Joost
    Insalaco, Antonella
    Anton, Jordi
    Kone-Paut, Isabelle
    Legger, G. Elizabeth
    Fabio, Giovanna
    Cattalini, Marco
    Kamphuis, Sylvia
    Hachulla, Eric
    Krause, Karoline
    Ekinci, Zelal
    Sanchez-Manubens, Judith
    van den Berg, J. Merlijn
    Mora, Cristina Herrera
    Brinkman, Danielle
    Labrador, Eztizen
    Potjewijd, Judith
    Carlini, Luca
    Bustaffa, Marta
    Caorsi, Roberta
    Ruperto, Nicolino
    Gattorno, Marco
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (05)
  • [39] Analysis of lumateperone data for patients with schizophrenia using related adverse events from the FDA adverse reporting system
    Sun, Shengzhu
    Zhang, Ying
    Wu, Hongyun
    Peng, Wei
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [40] Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
    Zhang, Qingxia
    Ding, Qian
    Yan, Suying
    Yue, Qun-Ying
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (09) : 1521 - 1526
12345